Theralase Technologies (CVE:TLT) Hits New 52-Week Low at $0.25
Shares of Theralase Technologies Inc. (CVE:TLT) hit a new 52-week low on Thursday . The stock traded as low as C$0.25 and last traded at C$0.26, with a volume of 1835780 shares trading hands. The stock had previously closed at C$0.27.
The firm has a 50 day simple moving average of C$0.34 and a two-hundred day simple moving average of C$0.44. The company has a market capitalization of $38.92 million and a PE ratio of -9.23.
Theralase Technologies (CVE:TLT) last announced its earnings results on Thursday, May 30th. The company reported C($0.01) earnings per share for the quarter. The business had revenue of C$0.12 million during the quarter.
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Photo Dynamic Therapy and Therapeutic Laser Technology.
Featured Story: Day Trading – Risk Worth the Reward?
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.